North America Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Geography

 

North America Swine Vaccines Market

Market Outline: 

Vaccines are the biological preparations that provide acquired immunity to the particular disease. North America Swine Vaccines Market typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy.

Market Dynamics:

• Increase in the demand for healthy pork meat and rise in pork meat production
• Rise in R&D expenditure for the innovation of newer vaccines and launching of vaccines into the market
• Rise in prevalence of various infectious diseases

Restraints

• Stringent regulatory policies for the swine vaccine approval
• Adverse effects such as allergies associated with the vaccines
• High cost of vaccines and lack of disease awareness in veterinary professionals

Market Scope: 

North America market is segmented on the basis of vaccine type, disease type, distribution channel, and country

Based on the vaccine type, North America market is segmented into the following

• Inactivated Vaccines
• Recombinant vaccines
• Live attenuated vaccines
• DNA vaccines
• Subunit vaccines
• Others

Based on the disease type, North America market is segmented into the following

• Viral Infections
• Bacterial Infections
• Parasitic Infection
• Fungal Infections
• Others

Based on the distribution channel, North America market is segmented into the following:

• Veterinary Hospitals
• Veterinary Pharmacies
• Online Pharmacies

Based on the country, North America market is segmented into the following:

• U.S.
• Canada

Competition Assessment: 

Some of the players in the North America market include:

• Zoetis (Pfizer, Inc.) (U.S.)
• Merck & Co. Inc. (U.S)
• Virbac S.A. (France)
• Boehringer Ingelheim Vetmedica (Germany)
• Elanco (U.S.)
• Bayer Animal Health (Germany)
• Ceva Sante Animale (France)

Notable Market Developments: 

• In September 2015, Merck Animal Health launched ileitis vaccine for finishing pigs in U.S.

Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies and regulatory framework
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

---

Location

GEOGRAPHY